Search results
Here's What Key Metrics Tell Us About Skyward (SKWD) Q2 Earnings
Skyward Specialty Insurance (SKWD) reported $489.53 million in revenue for the quarter ended June 2026, representing a year-over-year increase of 53%. EPS of $1.30 for the same period compares to
IperionX Targets 200-Ton Titanium Run Rate as U.S. Supply Chain Takes Shape
Key Points
- Interested in IperionX Limited Sponsored ADR? Here are five stocks we like better.
- IperionX is targeting an annualized titanium production rate of 200 metric tons by year-end at its
Match Group Q2 Earnings Call Highlights
Key Points
- Interested in Match Group Inc.? Here are five stocks we like better.
- Match Group reported mixed Q2 results: Revenue fell 1% year over year to $853 million, while adjusted EBITDA
EQS-News: Erfolgreiches erstes Halbjahr mit anhaltender Dynamik im Segment Research – Ausblick für das Gesamtjahr angepasst
Antifreeze Protein Market Growth Through Expanding Industrial Uses
DAX vor neuem Hoch, Unternehmenszahlen rücken in den Fokus
Der DAX dürfte seine Rekordjagd am Mittwoch fortsetzen und erneut ein Höchstniveau erreichen. Auch der Euro Stoxx 50 wird vor Handelsbeginn fester erwartet. Positive Impulse kommen von den
Leidos Q2 Earnings Call Highlights
Leidos (NYSE:LDOS) reported second-quarter fiscal 2026 revenue growth of 7% year over year to a record $4.56 billion, supported by demand
Compass Pathways Q2 Earnings Call Highlights
Key Points
- Interested in Compass Pathways PLC Sponsored ADR? Here are five stocks we like better.
- Compass Pathways remains on track to file for FDA approval of COMP360 for treatment-resistant
Klöckner & Co SE Q2 Earnings Call Highlights
Key Points
- Interested in Klöckner & Co SE? Here are five stocks we like better.
- Q2 EBITDA before special effects reached €63 million, placing Klöckner & Co in the upper half of its €170
QSR to Report Q2 Earnings: Burger King, Tim Hortons in Spotlight
Restaurant Brands International Inc. QSR is scheduled to report second-quarter 2026 results on Aug. 6, before the opening bell.In the previous quarter, the company’s earnings surpassed the Zacks
The Zacks Analyst Blog Highlights SpaceX, Advanced Micro Devices and Booking.com
For Immediate Release
Chicago, IL – August 5, 2026 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest
ETFs in Spotlight as First Solar Shares Jump Post Q2 Earnings Beat
Shares of First Solar Inc. FSLR gained 2.5% on July 31, 2026, following the release of its second-quarter results after the market closed on July 30. The stock continued its upward momentum over
CDW Q2 Earnings & Sales Beat, Soar Y/Y on AI & Infrastructure Spending
CDW Corporation CDW reported second-quarter 2026 non-GAAP earnings per share (EPS) of $2.91, beating the Zacks Consensus Estimate of $2.80. The bottom line increased approximately 12% year over
Lumen Posts Narrower-Than-Expected Q2 Loss, Revenues Drop Y/Y
Lumen Technologies, Inc. LUMN reported a second-quarter 2026 adjusted loss (excluding special items) of 7 cents per share, narrower than the Zacks Consensus Estimate of a loss of 15 cents. The
Is the Options Market Predicting a Spike in Vista Energy Stock?
Investors in Vista Energy, S.A.B. de C.V. VIST need to pay close attention to the stock based on moves in the options market lately. That is because the Aug 21, 2026 $20 Put had some of the highest
Is the Options Market Predicting a Spike in Apple Hospitality Stock?
Investors in Apple Hospitality REIT, Inc. APLE need to pay close attention to the stock based on moves in the options market lately. That is because the October 16, 2026 $22.50 Put had some of the
SYRE's Q2 Loss Narrower Than Expected, Pipeline Progresses
Spyre Therapeutics SYRE incurred a loss of 36 cents per share in the second quarter of 2026, narrower than the Zacks Consensus Estimate of a loss of 71 cents. In the year-ago quarter, the company
Bear of the Day: Boston Scientific (BSX)
Boston Scientific (BSX) manufactures medical devices and products used in various interventional medical specialties worldwide, including cardiovascular and surgical categories.On July 29, BSX
ONON Stock Decision Growth Potential Versus Premium Valuation Now
Investors evaluating On Holding AG ONON must balance a fast-growing premium sportswear business against a valuation that already assumes continued execution. The company is expanding sales, earnings
Can ADTRAN's AI Networking Push Offset Near-Term Execution Risks?
AI infrastructure spending is reshaping the optical networking industry, creating new opportunities for equipment vendors that can deliver higher-capacity connectivity solutions. For ADTRAN